The First Phase Key details and approval criteria for liraglutide (Saxenda) for weight management include a target patient age of 18 years and older with a body mass index (BMI) of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia
[DOI] [PubMed] Ramachandran A, Duan L, Akakpo JY, Jaeschke H
HSA and FSA accounts are eligible for payment, which can further reduce your out-of-pocket expense
It is NOT due to people with obesity not having enough willpower
Nestle, for instance, has launched a consumer-facing nutrition support platform that positions their Garden of Life, Natures Bounty and Boost brands for this growing audience
Learn more about KFF .